Brief: Agenus - Closing Of Deals With Zydus Pharmaceuticals - SEC Filing
23/09/2025 23:03
Sept 23 (Reuters) - Agenus Inc AGEN.O: AGENUS INC - CLOSING OF DEALS WITH ZYDUS PHARMACEUTICALS (USA) SHIFTED TO Q4 2025 - SEC FILING Source text: [ID:n0001193125-25-213574] Further company coverage: AGEN.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Agenus
See all newsBrief: Agenus Reports 72% Of Patients With Locally Advanced Dmmr Colon Cancer Had No Cancer Remaining At Surgery Following Six Weeks Of Bot+Bal In Phase 2 Neoasis Study At Esmo 2026
Brief: Armenia Grants First Marketing Authorizations For Agenus’ Bot+Bal In Previously Treated Mss Metastatic Colorectal Cancer
Brief: Agenus - Unit Enters Second Loan Modification Agreement With Ocean 1181 On Aug 12, 2026 - SEC Filing
Agenus Inc reports results for the quarter ended June 30 - Earnings Summary
Agenus Q2 revenue rises on access and royalty income